IDYA
IDEAYA Biosciences, Inc.
31.64
USD
This page is just a preview of the data found in TrendSpider’s full version
IDEAYA Biosciences, Inc. stock is up 9.25% since 30 days ago. The next earnings date is Mar 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 80% of the previous 4 December’s closed higher than November. 100% of analysts rate it a buy.
IDEAYA Biosciences, Inc. focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include a methionine adenosyltransferase 2a inhibitor that is in Phase I clinical trial for patients with solid tumors having methylthioadenosine phosphorylase deletions.
